Plasma fibronectin is a prognostic biomarker of disability in Parkinson's disease: a prospective, multicenter cohort study.
Zhu S, Li H, Huang Z, Zeng Y, Huang J, Li G, Yang S, Zhou H, Chang Z, Xie Z, Que R, Wei X, Li M, Liang Y, Xian W, Li M, Pan Y, Huang F, Shi L, Yang C, Deng C, Batzu L, Poplawska-Domaszewicz K, Chen S, Chan LL, Ray Chaudhuri K, Tan EK, Wang Q.
Zhu S, et al. Among authors: poplawska domaszewicz k.
NPJ Parkinsons Dis. 2025 Jan 2;11(1):1. doi: 10.1038/s41531-024-00865-1.
NPJ Parkinsons Dis. 2025.
PMID: 39747089
Free PMC article.